XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 32.93

+2.9%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: BostonView who wrote (7593)	10/30/1998 9:21:00 AM
From: jackie	Read Replies (2) of 17367

Thanks for this information. Just setting aside for the moment the eventual value of an effective treatment for endotoxin related pathologies, think about the value of a reliable diagnostic for same. As the article points out, such a tool would find utility in millions of cases involving real or suspected gram negative infections. LBP, as pointed out many times on this thread, is not just another sideshow. It would be a valuable tool for the clinical worker. Very good news. Perhaps this is what has caused the rise in the stock price recently? Jack

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next